JUNE 10, 2025 — UTSA researchers in the Max and Minnie Tomerlin Voelcker CIDD Preclinical Pharmacology Core for Accelerated ...

Shares of OneSource Specialty Pharma hit a new high of ₹2,031.45 in Tuesday's intra-day trade in otherwise a subdued market ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

Ohtuvayre's rapid US launch boosts Verona's growth with Q1 2025 sales up 95%. Read more on VRNA stock's blockbuster potential ...

The Trump administration recently released an executive order directing Medicare and Medicaid drug reimbursement to be based ...

Health New England announced Monday that it will shift coverage of the biologic drug Humira to more affordable FDA-approved biosimilars starting next month for members of its commercial health ...

Long before the terrorist attack, cracks in the Colorado city's progressive utopia were on display due to homelessness, a ...

Billionaire businessman and "Shark Tank" star Mark Cuban called out legislation being considered in Minnesota to regulate pharmacy benefit managers (PBMs), the companies accused by the FTC of ...

CVS Caremark identified GLP-1 drugs and Humira as points of contention, but the State Health Plan says that mischaracterizes ...

Pfizer and other drug companies met with the Trump administration to discuss lowering U.S. drug prices but no commitments ...

Weight-loss drugs. Senate Bill 244 (State Sen. Roberta Lange, D) would have expanded the types of obesity treatments covered ...

Phathom Pharmaceuticals, Inc. has secured 10 years of FDA exclusivity for Voquezna in GERD, boosting its stock. Click here to ...